Combined linkage and association studies show that HLA class II variants control levels of antibodies against Epstein-Barr virus antigens.
Pedergnana V, Syx L, Cobat A, Guergnon J, Brice P, Fermé C, Carde P, Hermine O, Le-Pendeven C, Amiel C, Taoufik Y, Alcaïs A, Theodorou I, Besson C, Abel L.
Pedergnana V, et al. Among authors: abel l.
PLoS One. 2014 Jul 15;9(7):e102501. doi: 10.1371/journal.pone.0102501. eCollection 2014.
PLoS One. 2014.
PMID: 25025336
Free PMC article.